DTM short interest hits a year-high with eight days to the print

Short interest in DT Midstream has reached its highest level in at least a year, now at 6.5% of the free float, and the stock has dropped 3.2% over the past week to $122.48 while the October 29 earnings date draws closer.

The short position has grown steadily and quickly. Shares short climbed to roughly 6.65 million as of October 20, up 19.5% over the past month and another 2.4% in the past week alone. That is a sustained, deliberate rebuild, not a spike. What has changed since the note published four days ago is that the position has continued to grow even as the stock sold off, suggesting shorts are not covering into weakness. The borrow market remains permissive: availability is running at 458%, meaning there are roughly four and a half shares available to borrow for every one already short, though that figure has tightened from 511% a week ago. Cost to borrow is 0.50%, up 6.5% on the week but still trivially cheap. Shorts face no friction. Options positioning is also calm: the put/call ratio of 0.08 is virtually in line with its 20-day average, with a z-score close to zero. Monday's PCR spike to 0.26 was the 52-week high but proved a single-day move. The overall picture is directional short-selling, not hedging or squeeze pressure.

DTM's week was notably weaker than most of its midstream peers. WMB fell 5.7% and ET dropped 4.5%, so some of the pressure is sector-wide. But KMI closed the week up 0.4%, OKE was down less than 1%, and AM lost only 2.4%. Against the median peer move of roughly -1.4%, DTM's 3.2% decline stands out, and the rebuilding short position suggests at least part of the underperformance reflects active positioning rather than passive sector rotation.

The Street's view is cautious and trending more so. Morgan Stanley maintained its Overweight rating this week but cut its price target to $164 from $170, the second time the firm has acted on DTM in six weeks after upgrading to Overweight in September. Barclays trimmed its Equal-Weight target to $142 in early October. Jefferies and Scotiabank also cut targets over the past six weeks, with Jefferies dropping its Buy target from $155 to $145. No firm has raised a target in recent weeks. The mean analyst target is $151.07, a 23% premium to the current price, but the direction of revisions is uniformly down. The bear case centres on $3.32 billion in debt, heavy revenue concentration in Haynesville and Northeast assets, and exposure to a single large counterparty in Expand Energy. Bulls point to the $3.4 billion organic project backlog, up 50%, and the 5-7% annual dividend growth target backed by take-or-pay contracts. On valuation, the PE has compressed to 25.5x over the past month while EV/EBITDA has edged down to 12.5x. The dividend factor score ranks in the 96th percentile, but short-score rank sits in the 14th percentile, reflecting the pressure building in the short book.

Insider activity over the past 90 days adds a mild contrarian note. The CFO, Jeffrey Jewell, bought shares in open-market transactions in late August at $133.78 and again in May at $147.73. A director also bought 1,500 shares at $132.61 in early August, none of the trades under a 10b5-1 plan. The net open-market position over 90 days is a modest positive at roughly 1,795 shares and $240,000 in value, with all purchases at prices above the current $122.48. The stock is now trading below every open-market purchase price on record in this window.

After the most recent quarterly print in late July, DTM moved just 1.5% on the day but fell 3.9% over the following five sessions. The pattern of a muted initial reaction followed by drift is worth noting as the October 29 release approaches. The specific question is whether the short rebuild since early October reflects a view on the print itself or on the guidance update, given that the stock's fee-based structure usually limits earnings surprises. The price at which analysts have been revising targets down converges around the $145 to $170 range, all well above the current level, so the gap between the short position and analyst consensus is the central tension to track into next Wednesday.